Lv1
30 积分 2023-12-11 加入
Venetoclax plus high-dose cytarabine and mitoxantrone as salvage treatment for relapsed or refractory acute myeloid leukaemia (RELAX): a multicentre, single-arm, phase 1/2 trial
5个月前
已关闭
Age-adapted chemotherapy and MRD-oriented transplant for Ph-negative acute lymphoblastic leukemia: the GRAALL-2014 trial
5个月前
已关闭
Venetoclax and Decitabine vs Intensive Chemotherapy as Induction for Young Patients with Newly Diagnosed AML
9个月前
已完结
Venetoclax plus hypomethylating agents versus priming regimen as the first-line therapy for newly diagnosed acute myeloid leukemia with myelodysplasia-related changes: a propensity score-matched analysis
11个月前
已完结
Overcoming Chemotherapy Resistance in EBF1–PDGFRB‐Positive B‐ALL: A Novel Therapeutic Approach Using Dasatinib and Blinatumomab
1年前
已完结
Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia: a pilot study
1年前
已关闭
皖公网安备34019202002308
